We have synthesized a VEGFR2-targeted peptide VRBP1 and developed a novel dual-modality probe based on VRBP1 and UCL materials to perform optical/MR imaging in murine models, which allowed non-invasive assessment of angiogenesis in plaques and early diagnosis of unstable atherosclerosis. The gene discussed is KDR; the disease is atherosclerosis.